| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.28 | 5e-08 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 5e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |